TSW
STJ

Thompson Siegel & Walmsley’s St Jude Medical STJ Stock Holding History

Thompson Siegel & Walmsley’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-75
Closed -$5K – 745
2015
Q3 		$5K Hold
75
– – ﹤0.01% 667
2015
Q2 		$5K Hold
75
– – ﹤0.01% 659
2015
Q1 		$5K Hold
75
– – ﹤0.01% 666
2014
Q4 		$5K Buy
+75
New +$4.83K ﹤0.01% 667

Other funds holding STJ

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Thompson Siegel & Walmsley's STJ Position: Q4 2015 in Review

Thompson Siegel & Walmsley sold out of St Jude Medical (STJ) in Q4 2015, closing a stake of 75 shares — an estimated $5K sold.

Thompson Siegel & Walmsley first reported a position in STJ in Q4 2014 and held it in 4 quarters. The position peaked at $5K in Q3 2015. 620 funds tracked by Wall St. Rank hold STJ as of Q4 2015.

  • Thompson Siegel & Walmsley reported no remaining St Jude Medical position as of Q4 2015 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 75 St Jude Medical shares in Q4 2015, an estimated $5K.
  • Thompson Siegel & Walmsley first reported a position in St Jude Medical in Q4 2014 and held it in 4 quarters.
  • Thompson Siegel & Walmsley's St Jude Medical position peaked at $5K in Q3 2015.
  • 620 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2015.

Based on Thompson Siegel & Walmsley's 13F filing for Q4 2015, filed 28 Jan 2016.